

article
NIAID-UofU study suggests existing drug could limit COVID-19 lung damage
A drug that blocks danger signals that can lead to harmful inflammation could help reduce COVID-19 lung damage, a new study from National Institute of Allergy and Infectious Diseases (NIAID) scientists and colleagues has found. Scientists from NIAID’s Rocky Mountain Laboratories in Hamilton,...